RNF125

ring finger protein 125, the group of Ring finger proteins

Basic information

Region (hg38): 18:32018825-32088144

Links

ENSG00000101695NCBI:54941OMIM:610432HGNC:21150Uniprot:Q96EQ8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Tenorio syndrome (Strong), mode of inheritance: AD
  • Tenorio syndrome (Limited), mode of inheritance: AD
  • Tenorio syndrome (Limited), mode of inheritance: AD
  • Tenorio syndrome (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Tenorio syndromeADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingAllergy/Immunology/Infectious; Musculoskeletal; Neurologic25196541

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RNF125 gene.

  • Tenorio_syndrome (48 variants)
  • Inborn_genetic_diseases (24 variants)
  • not_provided (14 variants)
  • RNF125-related_disorder (9 variants)
  • not_specified (6 variants)
  • Hypertrophic_cardiomyopathy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF125 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000017831.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
7
clinvar
5
clinvar
12
missense
1
clinvar
2
clinvar
39
clinvar
8
clinvar
2
clinvar
52
nonsense
0
start loss
0
frameshift
3
clinvar
3
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total 1 2 43 15 7

Highest pathogenic variant AF is 0.00000806739

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RNF125protein_codingprotein_codingENST00000217740 654842
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00004640.6671257180301257480.000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7831091350.8100.000007131506
Missense in Polyphen3039.5840.75788479
Synonymous0.3544649.20.9360.00000238438
Loss of Function0.893811.20.7135.56e-7145

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002350.000235
Ashkenazi Jewish0.000.00
East Asian0.0004910.000489
Finnish0.00004630.0000462
European (Non-Finnish)0.00007980.0000791
Middle Eastern0.0004910.000489
South Asian0.00009860.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of target proteins, such as DDX58/RIG-I, MAVS/IPS1, IFIH1/MDA5, JAK1 and p53/TP53 (PubMed:15843525, PubMed:17460044, PubMed:17643463, PubMed:26027934, PubMed:26471729, PubMed:25591766, PubMed:27411375). Acts as a negative regulator of type I interferon production by mediating ubiquitination of DDX58/RIG-I at 'Lys-181', leading to DDX58/RIG-I degradation (PubMed:17460044, PubMed:26471729). Mediates ubiquitination and subsequent degradation of p53/TP53 (PubMed:25591766). Mediates ubiquitination and subsequent degradation of JAK1 (PubMed:26027934). Acts as a positive regulator of T-cell activation (PubMed:15843525). {ECO:0000269|PubMed:15843525, ECO:0000269|PubMed:17460044, ECO:0000269|PubMed:17643463, ECO:0000269|PubMed:25591766, ECO:0000269|PubMed:26027934, ECO:0000269|PubMed:26471729, ECO:0000269|PubMed:27411375}.;
Disease
DISEASE: Tenorio syndrome (TNORS) [MIM:616260]: A disease characterized by overgrowth, macrocephaly, and intellectual disability. Some patients may have mild hydrocephaly, hypoglycemia, and inflammatory diseases resembling Sjogren syndrome. {ECO:0000269|PubMed:25196541}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
RIG-I-like receptor signaling pathway - Homo sapiens (human);RIG-I-like Receptor Signaling (Consensus)

Recessive Scores

pRec
0.102

Intolerance Scores

loftool
0.309
rvis_EVS
0.55
rvis_percentile_EVS
81.38

Haploinsufficiency Scores

pHI
0.600
hipred
N
hipred_score
0.459
ghis
0.390

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.449

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rnf125
Phenotype
hematopoietic system phenotype; immune system phenotype;

Gene ontology

Biological process
protein polyubiquitination;adaptive immune response;ubiquitin-dependent protein catabolic process;negative regulation of type I interferon production;negative regulation of RIG-I signaling pathway
Cellular component
Golgi membrane;VCP-NPL4-UFD1 AAA ATPase complex;intracellular membrane-bounded organelle
Molecular function
p53 binding;protein binding;zinc ion binding;ubiquitin conjugating enzyme binding;ubiquitin protein ligase activity